Intra-cellular Therapies Inc (ITCI) SVP of Finance CFO Lawrence J. Hineline Sold $513,730 of Shares

Author's Avatar
Jan 11, 2020
Article's Main Image

SVP of Finance CFO of Intra-cellular Therapies Inc (30-Year Financial, Insider Trades) Lawrence J. Hineline (insider trades) sold 19,638 shares of ITCI on 01/09/2020 at an average price of $26.16 a share. The total sale was $513,730.

Intra-Cellular Therapies Inc is a biopharmaceutical company. It is engaged in discovery and clinical development of small molecule drugs that address underserved medical needs in neuropsychiatric and neurological disorders. Intra-Cellular Therapies Inc has a market cap of $1.44 billion; its shares were traded at around $25.90 . GuruFocus has detected 3 severe warning signs with Intra-Cellular Therapies Inc. .

CEO Recent Trades:

  • Chairman, President & CEO Sharon Mates sold 41,895 shares of ITCI stock on 01/09/2020 at the average price of $26.16. The price of the stock has decreased by 0.99% since.
  • Chairman, President & CEO Sharon Mates sold 45,598 shares of ITCI stock on 01/06/2020 at the average price of $30.28. The price of the stock has decreased by 14.46% since.
  • Chairman, President & CEO Sharon Mates sold 17,478 shares of ITCI stock on 01/02/2020 at the average price of $32.45. The price of the stock has decreased by 20.18% since.

CFO Recent Trades:

  • SVP of Finance CFO Lawrence J. Hineline sold 19,638 shares of ITCI stock on 01/09/2020 at the average price of $26.16. The price of the stock has decreased by 0.99% since.
  • SVP of Finance CFO Lawrence J. Hineline sold 21,458 shares of ITCI stock on 01/06/2020 at the average price of $30.29. The price of the stock has decreased by 14.49% since.
  • SVP of Finance CFO Lawrence J. Hineline sold 7,807 shares of ITCI stock on 01/02/2020 at the average price of $32.43. The price of the stock has decreased by 20.14% since.
  • SVP of Finance CFO Lawrence J. Hineline sold 15,032 shares of ITCI stock on 12/23/2019 at the average price of $25.5. The price of the stock has increased by 1.57% since.

Directors and Officers Recent Trades:

  • EVP and Chief Medical Officer Andrew Satlin sold 11,573 shares of ITCI stock on 01/09/2020 at the average price of $26.16. The price of the stock has decreased by 0.99% since.
  • EVP and General Counsel Michael Halstead sold 19,638 shares of ITCI stock on 01/09/2020 at the average price of $26.16. The price of the stock has decreased by 0.99% since.
  • EVP and General Counsel Michael Halstead sold 21,458 shares of ITCI stock on 01/06/2020 at the average price of $30.34. The price of the stock has decreased by 14.63% since.
  • EVP and General Counsel Michael Halstead sold 7,807 shares of ITCI stock on 01/02/2020 at the average price of $32.43. The price of the stock has decreased by 20.14% since.

For the complete insider trading history of ITCI, click here

.